FDA Staff Questions Value of Implant Data (Reuters)


Reuters - New data from Inamed Corp. and rival
Mentor Corp. on their silicone breast implants are of "limited
value" in assessing the risk of ruptures, U.S. regulatory staff
said in reports made public on Wednesday.

Read more...